Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Akizza 75mcg /30 mcg tablets

Active Ingredient:
ethinylestradiol , gestodene
Company:  
Morningside Healthcare Ltd See contact details
ATC code: 
G03AA10
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Checklist for Prescribers - Akizza 75 mcg 30 mcg tablets

{healthcare_pro_orange} For Healthcare Professionals
Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations
{pdf_link}

Important Information leaflet - Akizza 75mcg/30mcg Tablets

All women should understand the small risk of blood clots with the combined hormonal contraceptives; what other conditions increase the risk of a blood clot; the signs and symptoms of a blood clot; when you need to tell a healthcare professional that you are using a combined hormonal contraceptive.
{pdf_link}

Patient Alert Card - Akizza 75mcg/30mcg Tablets

Important information for women about risk of blood clots with combined hormonal contraceptives.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Morningside Healthcare Ltd
Company image
Address
Morningside House, Unit C Harcourt Way, Meridian Business Park, Leicester, LE19 1WP
WWW
http://www.morningsidehealthcare.com
Telephone
+44 (0)116 204 5950
Medical Information Direct Line
+44 (0)116 478 0322
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)116 204 5950
Stock Availability
+44 (0)1509 217 705